单药治疗-话题@MedSci

#单药治疗#

130篇内容 | 2992人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1687735, encodeId=6ae7168e735e6, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Blood：Ivosidenib 单药治疗新确诊的AML的疗效和安全性, objectType=article, longId=185067, objectId=0f6418506ed8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f6418506ed8, replyNumber=0, likeNumber=61, createdTime=2020-08-19, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f6418506ed8, moduleTitle=Blood：Ivosidenib 单药治疗新确诊的AML的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f6418506ed8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687737, encodeId=6f02168e7376c, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Blood：Avadomide(CC-122)单药治疗难治性/复发性DLBCL的疗效和安全性, objectType=article, longId=187353, objectId=19ef18e35330, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19ef18e35330, replyNumber=0, likeNumber=54, createdTime=2020-03-27, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19ef18e35330, moduleTitle=Blood：Avadomide(CC-122)单药治疗难治性/复发性DLBCL的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19ef18e35330)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687738, encodeId=2096168e738a7, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle= Eur Respir J：抗药性肺结核患者使用贝达奎林-达拉米尼联合治疗是否优于贝达奎林单药治疗的效果？, objectType=article, longId=191951, objectId=4482191951c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4482191951c9, replyNumber=0, likeNumber=75, createdTime=2021-02-14, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4482191951c9, moduleTitle= Eur Respir J：抗药性肺结核患者使用贝达奎林-达拉米尼联合治疗是否优于贝达奎林单药治疗的效果？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4482191951c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687741, encodeId=bb0c168e741bf, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Lancet oncol：III期试验：ripretinib单药治疗晚期胃肠间质肿瘤的疗效和安全性, objectType=article, longId=195474, objectId=2d9e1954e445, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d9e1954e445, replyNumber=0, likeNumber=71, createdTime=2020-11-02, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d9e1954e445, moduleTitle=Lancet oncol：III期试验：ripretinib单药治疗晚期胃肠间质肿瘤的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d9e1954e445)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687732, encodeId=4e53168e73298, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Blood：派姆单抗单药治疗RRcHL可获得持久的缓解, objectType=article, longId=177653, objectId=fb891e765330, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb891e765330, replyNumber=0, likeNumber=69, createdTime=2020-05-18, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb891e765330, moduleTitle=Blood：派姆单抗单药治疗RRcHL可获得持久的缓解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb891e765330)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687733, encodeId=e02a168e7334a, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=TCT 2019 | TWILIGHT研究重磅发布，高危PCI患者使用替格瑞洛单药治疗获益显著, objectType=article, longId=180192, objectId=981118019267, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=981118019267, replyNumber=0, likeNumber=67, createdTime=2020-04-03, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=981118019267, moduleTitle=TCT 2019 | TWILIGHT研究重磅发布，高危PCI患者使用替格瑞洛单药治疗获益显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=981118019267)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687731, encodeId=9cd6168e73145, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=JAMA：P2Y12抑制剂单药治疗对PCI患者心血管事件的影响研究, objectType=article, longId=173295, objectId=7d9e1e32952a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d9e1e32952a, replyNumber=0, likeNumber=92, createdTime=2020-04-14, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d9e1e32952a, moduleTitle=JAMA：P2Y12抑制剂单药治疗对PCI患者心血管事件的影响研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d9e1e32952a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687734, encodeId=3f9c168e7349f, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=PD-1单抗单药治疗双原发癌，局部晚期肺鳞癌肿瘤疗效PR，肝细胞癌肿瘤疗效评估pCR, objectType=article, longId=184137, objectId=74cc18413e05, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74cc18413e05, replyNumber=0, likeNumber=95, createdTime=2019-12-31, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74cc18413e05, moduleTitle=PD-1单抗单药治疗双原发癌，局部晚期肺鳞癌肿瘤疗效PR，肝细胞癌肿瘤疗效评估pCR, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74cc18413e05)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687736, encodeId=69b2168e73690, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Blood：纳武单抗单药治疗有望治愈难治性/复发性EBV相关淋巴组织细胞增生症, objectType=article, longId=186026, objectId=bf6518602653, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf6518602653, replyNumber=0, likeNumber=53, createdTime=2020-05-05, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf6518602653, moduleTitle=Blood：纳武单抗单药治疗有望治愈难治性/复发性EBV相关淋巴组织细胞增生症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf6518602653)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687727, encodeId=951f168e7270a, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Lancet：Upadacitinib单药治疗甲氨蝶呤应答不充分的类风湿性关节炎, objectType=article, longId=167017, objectId=ba5d16e017b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba5d16e017b4, replyNumber=0, likeNumber=60, createdTime=2020-01-24, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba5d16e017b4, moduleTitle=Lancet：Upadacitinib单药治疗甲氨蝶呤应答不充分的类风湿性关节炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba5d16e017b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687730, encodeId=bb98168e73006, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=艾滋病预防新进展：CytoDyn和FDA将达共识以确定Leronlimab的关键单药治疗试验方案, objectType=article, longId=168073, objectId=a9591680e3d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9591680e3d9, replyNumber=0, likeNumber=62, createdTime=2019-08-29, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9591680e3d9, moduleTitle=艾滋病预防新进展：CytoDyn和FDA将达共识以确定Leronlimab的关键单药治疗试验方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9591680e3d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687728, encodeId=579e168e72800, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=帕博丽珠单抗单药治疗部分胃癌患者数据公布, objectType=article, longId=167666, objectId=cafa16e66654, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cafa16e66654, replyNumber=0, likeNumber=70, createdTime=2020-03-28, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cafa16e66654, moduleTitle=帕博丽珠单抗单药治疗部分胃癌患者数据公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cafa16e66654)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687726, encodeId=710e168e726f0, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=专家“亿”周谈—— J CLIN ONCOL：伊布替尼单药治疗症状型/初治型华氏巨球蛋白血症的全新突破, objectType=article, longId=164128, objectId=3027164128e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3027164128e1, replyNumber=0, likeNumber=62, createdTime=2019-09-25, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3027164128e1, moduleTitle=专家“亿”周谈—— J CLIN ONCOL：伊布替尼单药治疗症状型/初治型华氏巨球蛋白血症的全新突破, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3027164128e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687725, encodeId=0a19168e725c6, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Lancet：Pembrolizumab可单药治疗低PD-L1 TPS的晚期非小细胞肺癌, objectType=article, longId=163734, objectId=df88163e345a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df88163e345a, replyNumber=0, likeNumber=62, createdTime=2019-09-20, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df88163e345a, moduleTitle=Lancet：Pembrolizumab可单药治疗低PD-L1 TPS的晚期非小细胞肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df88163e345a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687724, encodeId=bbca168e724c3, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Clin Infect Dis：流感-MRSA肺炎的重症儿童：万古霉素单药治疗充分吗？, objectType=article, longId=161351, objectId=21231613518b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21231613518b, replyNumber=0, likeNumber=96, createdTime=2019-04-29, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21231613518b, moduleTitle=Clin Infect Dis：流感-MRSA肺炎的重症儿童：万古霉素单药治疗充分吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=21231613518b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687729, encodeId=f467168e72975, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=2019年ASCO：Umbralisib单药治疗边缘区淋巴瘤的阳性中期数据（UNITY-NHL试验）, objectType=article, longId=167755, objectId=817a16e7558a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=817a16e7558a, replyNumber=0, likeNumber=76, createdTime=2020-04-30, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=817a16e7558a, moduleTitle=2019年ASCO：Umbralisib单药治疗边缘区淋巴瘤的阳性中期数据（UNITY-NHL试验）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=817a16e7558a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687717, encodeId=d312168e7171b, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Obes Rev：单药治疗2型糖尿病，两种药物更有效, objectType=article, longId=149588, objectId=f29714958881, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f29714958881, replyNumber=0, likeNumber=102, createdTime=2019-02-02, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f29714958881, moduleTitle=Obes Rev：单药治疗2型糖尿病，两种药物更有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f29714958881)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687715, encodeId=abb0168e715dd, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Lancet：阿莫西林单药治疗儿童支气管扩张症恶化疗效研究, objectType=article, longId=149113, objectId=1fdf149113c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1fdf149113c3, replyNumber=0, likeNumber=58, createdTime=2019-01-23, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1fdf149113c3, moduleTitle=Lancet：阿莫西林单药治疗儿童支气管扩张症恶化疗效研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1fdf149113c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687720, encodeId=a881168e72011, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Blood：依鲁替尼联合利妥昔单抗与依鲁替尼单药治疗慢性淋巴细胞白血病的效果对比, objectType=article, longId=155412, objectId=d77e1554121e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d77e1554121e, replyNumber=0, likeNumber=62, createdTime=2019-01-22, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d77e1554121e, moduleTitle=Blood：依鲁替尼联合利妥昔单抗与依鲁替尼单药治疗慢性淋巴细胞白血病的效果对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d77e1554121e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687721, encodeId=638c168e7210d, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Inflam Bowel Dis：主动优化英夫利昔单抗单药治疗可以提高IBD治疗效果, objectType=article, longId=157178, objectId=612e15e17888, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=612e15e17888, replyNumber=0, likeNumber=67, createdTime=2019-03-04, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=612e15e17888, moduleTitle=Inflam Bowel Dis：主动优化英夫利昔单抗单药治疗可以提高IBD治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=612e15e17888)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

单药治疗

2020-05-29

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Blood：Ivosidenib 单药治疗新确诊的AML的疗效和安全性

2020-08-19

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Blood：Avadomide(CC-122)单药治疗难治性/复发性DLBCL的疗效和安全性

2020-03-27

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Eur Respir J：抗药性肺结核患者使用贝达奎林-达拉米尼联合治疗是否优于贝达奎林单药治疗的效果？

2021-02-14

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Lancet oncol：III期试验：ripretinib单药治疗晚期胃肠间质肿瘤的疗效和安全性

2020-11-02

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Blood：派姆单抗单药治疗RRcHL可获得持久的缓解

2020-05-18

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

TCT 2019 | TWILIGHT研究重磅发布，高危PCI患者使用替格瑞洛单药治疗获益显著

2020-04-03

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

JAMA：P2Y12抑制剂单药治疗对PCI患者心血管事件的影响研究

2020-04-14

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

PD-1单抗单药治疗双原发癌，局部晚期肺鳞癌肿瘤疗效PR，肝细胞癌肿瘤疗效评估pCR

2019-12-31

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Blood：纳武单抗单药治疗有望治愈难治性/复发性EBV相关淋巴组织细胞增生症

2020-05-05

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Lancet：Upadacitinib单药治疗甲氨蝶呤应答不充分的类风湿性关节炎

2020-01-24

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

艾滋病预防新进展：CytoDyn和FDA将达共识以确定Leronlimab的关键单药治疗试验方案

2019-08-29

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

帕博丽珠单抗单药治疗部分胃癌患者数据公布

2020-03-28

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

专家“亿”周谈—— J CLIN ONCOL：伊布替尼单药治疗症状型/初治型华氏巨球蛋白血症的全新突破

2019-09-25

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Lancet：Pembrolizumab可单药治疗低PD-L1 TPS的晚期非小细胞肺癌

2019-09-20

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Clin Infect Dis：流感-MRSA肺炎的重症儿童：万古霉素单药治疗充分吗？

2019-04-29

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

2019年ASCO：Umbralisib单药治疗边缘区淋巴瘤的阳性中期数据（UNITY-NHL试验）

2020-04-30

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Obes Rev：单药治疗2型糖尿病，两种药物更有效

2019-02-02

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Lancet：阿莫西林单药治疗儿童支气管扩张症恶化疗效研究

2019-01-23

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Blood：依鲁替尼联合利妥昔单抗与依鲁替尼单药治疗慢性淋巴细胞白血病的效果对比

2019-01-22

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Inflam Bowel Dis：主动优化英夫利昔单抗单药治疗可以提高IBD治疗效果

2019-03-04

科室
- - 订阅+
  - 更多科室
工具
服务